NORML Delivers Over 10,000 Public Comments To FDA Regarding International Classification Of Cannabis

fda-logo

DISTRICT OF COLUMBIA: NORML staffers on Wednesday hand-delivered over 10,000 public comments to the US Food and Drug Administration calling on the agency to recommend amending the substance’s illicit status under international treaties. The agency had requested public comments so that they could be “considered in preparing a response from the United States to the World Health Organization regarding the Read the full article…

FDA Calls for Public Comments Regarding International Classification Of Cannabis

MJLegal

MARYLAND: The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration. The FDA says that the comments “will be considered in preparing a response from the Read the full article…

Statement From FDA Commissioner Scott Gottlieb On Researching Medical Uses Of Cannabis

Statement by FDA Commissioner Scott Gottlieb, M.D., on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components

By Scott Gottlieb, MD DISTRICT OF COLUMBIA: Over the past decade, we’ve seen a growing interest in the development of therapies derived from marijuana and its components. Proponents of “medical marijuana” advertised its uses for a wide number of medical conditions, such as cancer, multiple sclerosis, post-traumatic stress disorder and anxiety – just to name Read the full article…

FDA Approves Marketing Of Plant-Derived Marijuana Medicine

GW Pharmaceuticals Epidiolex

DISTRICT OF COLUMBIA:  Regulators at the US Food and Drug Administration on Monday granted market approval to Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD) for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The proprietary extract formulation – developed by the British biotechnology firm GW Pharmaceuticals – had Read the full article…

FDA Approves First Cannabis-Based Epilepsy Drug

fda-logo

MARYLAND: The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from Read the full article…

Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA Clearance

OralTox

MINNESOTA: On February 2, 2018, Premier Biotech Inc. was granted a coveted 510(k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration (FDA) for OralTox, its flagship, patented rapid oral fluid drug screen device. A FDA 510(k) clearance is a significant achievement as it paves the Read the full article…

FDA Grants ‘Priority Review’ Of Plant-Derived CBD Extract

If Epidiolex achieves FDA-approval, analysts suggest the product could retail for between $30,000 to $60,000 annually.

DISTRICT OF COLUMBIA: Representatives of the US Food and Drug Administration will undertake a ‘priority review‘ of data specific to the safety and efficacy of Epidiolex, a standardized, plant-derived CBD extract formulated by a British pharmaceutical company. The review is scheduled to be completed by June 27, 2018. Phase III clinical trial data shows that Epidiolex Read the full article…

MMJ International Holdings Pursuing Legal FDA Cannabis Medicine Approval

fda-logo

NEW YORK: MMJ International Holdings announced that its affiliate, MMJ Bioscience, has finalized a partnership agreement with Terra Life Science group, a private Canadian based pharmaceutical manufacturer, to produce cannabis medicines for the groups FDA approved studies. Last weeks announcement by Attorney General Sessions on the recision of the Cole Memorandum positions MMJ International Holdings as Read the full article…

World Health Organization: CBD Should Not Be Subject To International Drug Controls

hemp CBD oil

SWITZERLAND: Use of the naturally occurring cannabinoid CBD (cannabidiol) possesses no likely abuse potential and should not be subject to international drug scheduling restrictions, according to recommendations issued this week by the World Health Organization’s (WHO) Expert Committee on Drug Dependence. Stated WHO: “Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due Read the full article…

iCan Israel-Cannabis To Bring FDA Approved Nebulizers To Medical Cannabis Market

The Nebican Portable Nebulizer for Medical Cannabis delivery

ISRAEL: iCAN Israel-Cannabis and Aura Medical have joined forces to bring FDA approved nebulizers to the burgeoning medical cannabis market. The Aura’s Portable Nebulizer is widely acclaimed and recommended by the nation’s top Pulmonologists and Respiratory Therapists for use in treating asthma and COPD and now will be used by millions more worldwide. The device will Read the full article…